NO20023102L - Fremgangsmåte og formulering for behandling av residens mot anti-hypertensiver og relaterte tilstander - Google Patents

Fremgangsmåte og formulering for behandling av residens mot anti-hypertensiver og relaterte tilstander

Info

Publication number
NO20023102L
NO20023102L NO20023102A NO20023102A NO20023102L NO 20023102 L NO20023102 L NO 20023102L NO 20023102 A NO20023102 A NO 20023102A NO 20023102 A NO20023102 A NO 20023102A NO 20023102 L NO20023102 L NO 20023102L
Authority
NO
Norway
Prior art keywords
antihypertensives
formulation
treatment
melatonin
related conditions
Prior art date
Application number
NO20023102A
Other languages
English (en)
Other versions
NO20023102D0 (no
NO322567B1 (no
Inventor
Nava Zisapel
Moshe Laudon
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Publication of NO20023102D0 publication Critical patent/NO20023102D0/no
Publication of NO20023102L publication Critical patent/NO20023102L/no
Publication of NO322567B1 publication Critical patent/NO322567B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
NO20023102A 2000-01-05 2002-06-27 Anvendelse av melatonin ved fremstilling av medikament for behandling av resistens mot anti-hypertensiva og relaterte tilstander NO322567B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IL2000/000009 WO2001049286A1 (en) 2000-01-05 2000-01-05 Method and formulation for treating resistance to antihypertensives and related conditions

Publications (3)

Publication Number Publication Date
NO20023102D0 NO20023102D0 (no) 2002-06-27
NO20023102L true NO20023102L (no) 2002-08-30
NO322567B1 NO322567B1 (no) 2006-10-30

Family

ID=11042938

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023102A NO322567B1 (no) 2000-01-05 2002-06-27 Anvendelse av melatonin ved fremstilling av medikament for behandling av resistens mot anti-hypertensiva og relaterte tilstander

Country Status (31)

Country Link
US (3) US7332177B1 (no)
EP (1) EP1272177B1 (no)
JP (1) JP4996803B2 (no)
CN (1) CN1414851A (no)
AT (1) ATE359072T1 (no)
AU (1) AU782266B2 (no)
BG (1) BG65637B1 (no)
BR (1) BR0016918A (no)
CA (1) CA2396129C (no)
CY (2) CY1108018T1 (no)
CZ (1) CZ299931B6 (no)
DE (1) DE60034373T2 (no)
DK (1) DK1272177T3 (no)
EA (1) EA004679B1 (no)
EE (1) EE200200379A (no)
ES (1) ES2284471T3 (no)
HK (1) HK1052655A1 (no)
HU (1) HU227002B1 (no)
IL (1) IL150190A0 (no)
IS (1) IS6439A (no)
MX (1) MXPA02005783A (no)
NO (1) NO322567B1 (no)
NZ (1) NZ520078A (no)
PL (1) PL201219B1 (no)
PT (1) PT1272177E (no)
SI (1) SI1272177T1 (no)
SK (1) SK287508B6 (no)
TR (1) TR200201724T2 (no)
TW (1) TWI260983B (no)
UA (1) UA77394C2 (no)
WO (1) WO2001049286A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL144900A (en) * 2001-08-14 2013-12-31 Neurim Pharma 1991 Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
US20050020666A1 (en) * 2003-07-25 2005-01-27 Dabur Research Foundation Cardioprotective agents
US20050137247A1 (en) * 2003-12-22 2005-06-23 The Brigham And Women's Hospital, Inc. Methods and compositions for treatment of hypertension
JP3964417B2 (ja) 2004-09-27 2007-08-22 国立大学法人金沢大学 インドール誘導体を有効成分とするα２受容体遮断剤及び血管拡張剤
KR101053780B1 (ko) * 2008-02-29 2011-08-02 동아제약주식회사 도세탁셀을 함유하는 단일액상의 안정한 약제학적 조성물
JP2013542531A (ja) * 2010-10-25 2013-11-21 ユイコ インコーポレイテッド 複雑な表面形状用のソリッドステートタッチセンサを備えた制御システム
US8691275B2 (en) 2011-01-28 2014-04-08 Zx Pharma, Llc Controlled-release melatonin compositions and related methods
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2018033546A1 (en) * 2016-08-18 2018-02-22 Koninklijke Philips N.V. Blood-pressure management
US10849856B2 (en) 2016-10-31 2020-12-01 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same
JP6830156B2 (ja) 2016-10-31 2021-02-17 ニューリム・ファーマシューティカルズ・リミテッドＮｅｕｒｉｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． メラトニンミニタブレットおよびその製造方法
WO2019038586A1 (en) 2017-08-19 2019-02-28 Ftf Pharma Private Limited PHARMACEUTICAL COMPOSITION OF MELATONIN
ES2724933A1 (es) * 2018-03-13 2019-09-17 Ocupharm Diagnostics Sl Terapia combinada con melatonina para la reducción de la presión intraocular
GB2617102A (en) * 2022-03-29 2023-10-04 John Hemming Trading Ltd Sleep therapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69229490T2 (de) 1991-05-09 2000-02-17 Neurim Pharmaceuticals (1991) Ltd., Tel Aviv Melatonin enthaltende Arzneimittel
ZA928011B (en) * 1991-10-18 1993-06-23 Alza Corp Transdermal administration of melatonin.
US5646049A (en) 1992-03-27 1997-07-08 Abbott Laboratories Scheduling operation of an automated analytical system
EP0565296B1 (en) 1992-04-07 1996-08-07 Neurim Pharmaceuticals (1991) Limited Use of melatonin for the manufacture of a medicament for the treatment of benign prostatic hyperplasia
EP0664339A4 (en) 1993-07-09 1999-04-28 Wakunaga Seiyaku Kk METHOD FOR DISCRIMINATION OF NUCLEIC ACIDS AND TEST KIT FOR THIS PURPOSE.
TR199700723T1 (xx) 1995-02-01 1998-02-21 Neurim Pharmaceuticals (1991) Ltd. Uyu�turucu (ila�) ba��ml�l���ndan zarar g�ren hastalar�n tedavisi i�in melatonin kullan�m�.
US5648727A (en) 1995-10-24 1997-07-15 Dpc Cirrus Inc. Capacitive level sensing pipette probe
US5700828A (en) * 1995-12-07 1997-12-23 Life Resuscitation Technologies, Inc. Treatment or prevention of anoxic or ischemic brain injury with melatonin-containing compositions
US5849338A (en) * 1996-04-10 1998-12-15 Chronorx Llc Unit dosage forms for treatment of vasoconstriction and related conditions
RU2134108C1 (ru) 1998-10-06 1999-08-10 Заславская Рина Михайловна Средство для лечения артериальной гипертонии, способ лечения артериальной гипертонии

Also Published As

Publication number Publication date
ES2284471T3 (es) 2007-11-16
AU782266B2 (en) 2005-07-14
EP1272177A4 (en) 2004-04-28
UA77394C2 (uk) 2006-12-15
JP2003519181A (ja) 2003-06-17
ATE359072T1 (de) 2007-05-15
CA2396129C (en) 2010-11-30
NO20023102D0 (no) 2002-06-27
EP1272177B1 (en) 2007-04-11
HU227002B1 (en) 2010-04-28
BG106978A (en) 2003-03-31
CN1414851A (zh) 2003-04-30
JP4996803B2 (ja) 2012-08-08
SK287508B6 (sk) 2010-12-07
WO2001049286A1 (en) 2001-07-12
EA004679B1 (ru) 2004-06-24
CZ299931B6 (cs) 2008-12-29
PT1272177E (pt) 2007-07-11
EE200200379A (et) 2003-10-15
PL201219B1 (pl) 2009-03-31
CA2396129A1 (en) 2001-07-12
TR200201724T2 (tr) 2003-03-21
CY1108018T1 (el) 2011-04-06
CY2007033I2 (el) 2009-11-04
US20120070501A1 (en) 2012-03-22
HUP0204089A3 (en) 2005-12-28
DE60034373D1 (de) 2007-05-24
NO322567B1 (no) 2006-10-30
MXPA02005783A (es) 2003-10-14
IS6439A (is) 2002-06-24
BG65637B1 (bg) 2009-04-30
HK1052655A1 (zh) 2003-09-26
US8728511B2 (en) 2014-05-20
TWI260983B (en) 2006-09-01
DK1272177T3 (da) 2007-08-06
PL356325A1 (en) 2004-06-28
CZ20022346A3 (cs) 2002-11-13
IL150190A0 (en) 2002-12-01
DE60034373T2 (de) 2007-12-20
US7332177B1 (en) 2008-02-19
SI1272177T1 (sl) 2007-10-31
NZ520078A (en) 2004-02-27
SK9732002A3 (en) 2002-11-06
AU1888200A (en) 2001-07-16
HUP0204089A2 (hu) 2003-04-28
US20080085317A1 (en) 2008-04-10
EP1272177A1 (en) 2003-01-08
EA200200738A1 (ru) 2002-12-26
US8075914B2 (en) 2011-12-13
BR0016918A (pt) 2004-03-23
CY2007033I1 (el) 2009-11-04

Similar Documents

Publication Publication Date Title
NO20023102L (no) Fremgangsmåte og formulering for behandling av residens mot anti-hypertensiver og relaterte tilstander
AU3104301A (en) Compositions and methods to effect the release profile in the transdermal administration of active agents
NO20070887L (no) Kornformet farmasoytisk preparat med tidsbegrenset frigivelse for oral administrasjon, og intraoral hurtig desintegrerende tablett som inneholder preparatet
IL225191A0 (en) A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders
PT1239849E (pt) Formulacoes farmaceuticas que compreendem resveratrol e a sua utilizacao
WO2004075832A3 (en) Methods and compositions for the treatment of chronic pain using dhea and derivatives thereof
DE60035574D1 (de) Formulierungen zur behandlung von krankheiten und verfahren unter deren verwendung
ATE311201T1 (de) Testosteron-ester formulierung zur anwendung am menschen
BRPI0406858A (pt) Liberação controlada de agentes altamente solúveis
SG153661A1 (en) Formulation and methods for the treatment of thrombocythemia
WO2004030623A3 (en) Nitroxide radioprotector formulations and methods of use
AU2003219664A1 (en) Methods and therapeutic compositions in the treatment of advanced cancer
ITMI20020872A1 (it) Derivati dell'iperforina loro uso e formulazioni che li contengono
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases
IL163431A (en) 1 - phenyl - 2 - heteroaryl - substituted benzimidazole derivatives and the use thereof for producing drugs used in the treatment of immunological diseases
MXPA05011249A (es) Combinaciones de desoxipeganina y mecamilamina para el tratamiento del abuso de alcohol.
WO2001074341A3 (en) Composition for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant
NO20030483D0 (no) Assosiasjoner av dalfopristin/quinupristin med cefpirom
ATE247961T1 (de) Sufentanilhaltige arzneimittel mit verzögerter wirkstoffabgabe
AU2003226859A1 (en) Use of thiophenes or bisthiophenes in compositions for the treatment of human keratin fibres compositions and methods comprising the same
TNSN00242A1 (en) VALDECOXIB COMPOSITIONS
WO2002072016A3 (en) Method of preventing adhesions with ifn-¿y?

Legal Events

Date Code Title Description
MK1K Patent expired